Outcome of Extracorporeal Photopheresis as Add-On Therapy in Patients for Antibody-Mediated Rejection after Lung Transplantation

A. Benazzo,S. Schwarz,T. Schweiger,A. Frick, G. Muraközy,C. Lambers,B. Moser,J. Matilla,G. Lang,S. Taghavi, W. Klepetko,K. Hoetzenecker,P. Jaksch

JOURNAL OF HEART AND LUNG TRANSPLANTATION（2020）

引用 0|浏览36

暂无评分

摘要

Extracorporeal photopheresis is associated with a reduction of de novo DSA after antibody-mediated rejection. Prospective studies are necessary to confirm the beneficial effect of ECP as an add-on therapy after AMR.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要